| William Bunn, DO | |
|
1145 S 800 E Ste 111, Orem, UT 84097-7273 | |
| (801) 704-5027 | |
| Not Available |
| Full Name | William Bunn |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1145 S 800 E Ste 111, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578662508 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 57566801204 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Bunn, DO 6694 W. Normandy Way, Highland, UT 84003 Ph: (385) 221-1144 | William Bunn, DO 1145 S 800 E Ste 111, Orem, UT 84097-7273 Ph: (801) 704-5027 |
News Archive
Long after a hangover, a night of bad decisions might take a bigger toll on the body than previously understood. Described in the current issue of Alcoholism: Clinical & Experimental Research, a study at the University of Missouri has revealed a unique connection between binge drinking and the risk for developing alcoholic liver disease and a variety of other health problems.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
This collaboration is carried out within the GastricGlycoExplorer consortium, a European Commission funded project. The consortium aims at discovering and developing new diagnostic signatures by characterizing the sugars that are attached to the surface of gastric tissue. "Glycomics" provides a systematic approach for studying sugars that are naturally present on cell surfaces and its application may lead to determine early markers of gastric cancer.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, today announced the launch of inForm™, advanced image analysis software based on the company's proprietary Machine Learning System (MLS). inForm solves biologists' and cancer researchers' challenging image analysis problems by combining fast and easy-to-use automated image processing with advanced learning features that enable the user to train the software to process images automatically.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 3 days ago
Dr. Neil Francis Rosenberg, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 750 W 800 N, Orem, UT 84057 Phone: 801-714-6235 | |
Dr. Douglas Scott Grover, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1350 E 750 N, Orem, UT 84097 Phone: 801-852-2273 | |
Dr. David L Paulson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 361 E 1200 S, Suite 201, Orem, UT 84058 Phone: 801-224-3014 Fax: 801-224-4914 | |
Dr. Reid J Robison, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1788 N State St, Orem, UT 84057 Phone: 801-839-5227 | |
Dr. Betty Howell Mcelroy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 777 N Palisades Dr, Orem, UT 84097 Phone: 801-222-9200 |